60 Minutes

Quote








Oh, I get it now... You libs have been destroyed in every conceivable way, so now you want CP to take down this thread. You try to post the most devoid of thought, ludicrous statements in the hopes that CP will destroy this account of the destruction of your misguided worldview.

Nice try LOSER!
 
























...

At the time the federal government filed its lawsuit, Novartis documents indicated that approximately 40% of Exjade sales were reimbursed by Medicaid, Medicare or other government health programs, according to court documents.

Two years ago, by the way, the feds also joined a separate whistleblower lawsuit filed by another former Novartis employee. He alleged that lavish trips and speaker dinners given for doctors were purportedly kickbacks and used to induce them to prescribe Novartis drugs, according to court documents (this is the lawsuit filed by the feds).

As the litigation plays out, a key issue to watch is the extent to which a so-called Corporate Integrity Agreement that Novartis signed in 2010 factors into the proceedings. These agreements typically run for five years and require a company to establish an internal compliance program and report violations.

At the time that Preet Bharara, the U.S. Attorney in New York, announced the lawsuits against Novartis two years ago, he called the drug maker a “repeat offender,” and the lawsuits noted that the violations alleged in the litigation took place before and after the CIA was signed.

On paper, this could pose a problem for Novartis, because if the drug maker loses one or both cases, it may face exclusion – a term that means it could be excluded from having contracts with federal health care programs. This could amount to a large loss of revenue.

On the other hand, the federal government may need to be cautious about excluding a drug maker that provides numerous needed medications, because doing so could unnecessarily harm many people.

One expert says exclusion is unlikely. “Do Corporate Integrity Agreements really matter? Show me a case where a company has violated a CIA and been excluded,” says Patrick Burns of Taxpayers Against Fraud, a non-profit that advocates for tough penalties and is partially funded by attorneys. “I’ve come to see Corporate Integrity Agreements as bird cage liner.”


http://blogs.wsj.com/pharmalot/2015...o-pay-60m-to-settle-novartis-kickback-scheme/



as exclusion appears to be the greater crime against humanity, any guesses on the timing and cost of the next settlement?

we've had at least 1/year since 2010.

do the math.



1987-07 $899,520 Sandoz PF Settling with European Union for infringing Article 85 (1) of the Treaty
1996-02 $41,300,000 Ciba-Geigy Settling class action suit for conspiring to illegally fix prices of drugs
1999-03 $10,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for failure to provide accurate pricing information for pharmaceuticals sold to VA
2000-01 $25,000,000 Alcon Inc. Settling with Bausch & Lomb Inc. for patent-infringement
2004-11 $175,000,000 Novartis Pharmaceutical Corporation Settling with 5,600 current & former saleswomen for gender discrimination
2005-02 $44,654,229 Novartis Pharmaceutical Corporation Settling FCA violations for giving free enteral nutrition infusion pumps if buying related products
2006-07 $121,000,000 Alcon Inc. Settling with Advanced Medical Optics Inc. over 4 patent lawsuits
2010-01 $185,000,000 Novartis Pharmaceutical Corporation Settling with federal officials over its marketing of epilepsy drug Trileptal
2010-02 $3,500,000 Novartis Pharmaceutical Corporation (Eon Labs Inc.) Settling FCA violations for unapproved product - Nitroglycerin
2010-03 $579,338 Novartis Pharmaceutical Corporation Settling with Mary Kate Breeden for retaliation under the Family & Medical Leave Act
2010-05 $72,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for off-label marketing
2010-07 $152,500,000 Novartis Pharmaceutical Corporation Settling gender discrimination class action lawsuit
2010-09 $422,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for off-label marketing
2010-10 $10,000,000 Novartis Pharmaceutical Corporation Settling with Hawaii for gouging Hawaii's Medicaid program for more than a decade by inflating prices
2011-09 $66,000,000 Novartis Pharmaceutical Corporation Settling FCA violations for overcharging Medicaid
2012-01 $99,170,000 Novartis Pharmaceutical Corporation Settling class-action lawsuit involving thousands of current & former employees for unpaid overtime
2013-12 $7,559,605 Novartis Pharmaceutical Corporation Settling with European Union for colluding with Johnson & Johnson to keep generic fentanyl out of Netherlands
2014-03 $126,340,273 Novartis Pharmaceutical Corporation Settling with Italy for colluding with Roche Holding to block Roche's Avastin drug for a more expensive one

https://docs.google.com/spreadsheets/d/1t0Tb5H7V_OkOuLM9kaiPmszXb3L5wS2g7Tc5dG7v9yM
 




Anonymous said:
...

At the time the federal government filed its lawsuit, Novartis documents indicated that approximately 40% of Exjade sales were reimbursed by Medicaid, Medicare or other government health programs, according to court documents.

Two years ago, by the way, the feds also joined a separate whistleblower lawsuit filed by another former Novartis employee. He alleged that lavish trips and speaker dinners given for doctors were purportedly kickbacks and used to induce them to prescribe Novartis drugs, according to court documents (this is the lawsuit filed by the feds).

As the litigation plays out, a key issue to watch is the extent to which a so-called Corporate Integrity Agreement that Novartis signed in 2010 factors into the proceedings. These agreements typically run for five years and require a company to establish an internal compliance program and report violations.

At the time that Preet Bharara, the U.S. Attorney in New York, announced the lawsuits against Novartis two years ago, he called the drug maker a “repeat offender,” and the lawsuits noted that the violations alleged in the litigation took place before and after the CIA was signed.

On paper, this could pose a problem for Novartis, because if the drug maker loses one or both cases, it may face exclusion – a term that means it could be excluded from having contracts with federal health care programs. This could amount to a large loss of revenue.

On the other hand, the federal government may need to be cautious about excluding a drug maker that provides numerous needed medications, because doing so could unnecessarily harm many people.

One expert says exclusion is unlikely. “Do Corporate Integrity Agreements really matter? Show me a case where a company has violated a CIA and been excluded,” says Patrick Burns of Taxpayers Against Fraud, a non-profit that advocates for tough penalties and is partially funded by attorneys. “I’ve come to see Corporate Integrity Agreements as bird cage liner.”


http://blogs.wsj.com/pharmalot/2015...o-pay-60m-to-settle-novartis-kickback-scheme/



as exclusion appears to be the greater crime against humanity, any guesses on the timing and cost of the next settlement?

we've had at least 1/year since 2010.

do the math.



1987-07 $899,520 Sandoz PF Settling with European Union for infringing Article 85 (1) of the Treaty
1996-02 $41,300,000 Ciba-Geigy Settling class action suit for conspiring to illegally fix prices of drugs
1999-03 $10,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for failure to provide accurate pricing information for pharmaceuticals sold to VA
2000-01 $25,000,000 Alcon Inc. Settling with Bausch & Lomb Inc. for patent-infringement
2004-11 $175,000,000 Novartis Pharmaceutical Corporation Settling with 5,600 current & former saleswomen for gender discrimination
2005-02 $44,654,229 Novartis Pharmaceutical Corporation Settling FCA violations for giving free enteral nutrition infusion pumps if buying related products
2006-07 $121,000,000 Alcon Inc. Settling with Advanced Medical Optics Inc. over 4 patent lawsuits
2010-01 $185,000,000 Novartis Pharmaceutical Corporation Settling with federal officials over its marketing of epilepsy drug Trileptal
2010-02 $3,500,000 Novartis Pharmaceutical Corporation (Eon Labs Inc.) Settling FCA violations for unapproved product - Nitroglycerin
2010-03 $579,338 Novartis Pharmaceutical Corporation Settling with Mary Kate Breeden for retaliation under the Family & Medical Leave Act
2010-05 $72,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for off-label marketing
2010-07 $152,500,000 Novartis Pharmaceutical Corporation Settling gender discrimination class action lawsuit
2010-09 $422,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for off-label marketing
2010-10 $10,000,000 Novartis Pharmaceutical Corporation Settling with Hawaii for gouging Hawaii's Medicaid program for more than a decade by inflating prices
2011-09 $66,000,000 Novartis Pharmaceutical Corporation Settling FCA violations for overcharging Medicaid
2012-01 $99,170,000 Novartis Pharmaceutical Corporation Settling class-action lawsuit involving thousands of current & former employees for unpaid overtime
2013-12 $7,559,605 Novartis Pharmaceutical Corporation Settling with European Union for colluding with Johnson & Johnson to keep generic fentanyl out of Netherlands
2014-03 $126,340,273 Novartis Pharmaceutical Corporation Settling with Italy for colluding with Roche Holding to block Roche's Avastin drug for a more expensive one

https://docs.google.com/spreadsheets/d/1t0Tb5H7V_OkOuLM9kaiPmszXb3L5wS2g7Tc5dG7v9yM
Click to expand...

I agree, we live in an overly litigious society... and we all pay the price.
 




Anonymous said:
...

At the time the federal government filed its lawsuit, Novartis documents indicated that approximately 40% of Exjade sales were reimbursed by Medicaid, Medicare or other government health programs, according to court documents.

Two years ago, by the way, the feds also joined a separate whistleblower lawsuit filed by another former Novartis employee. He alleged that lavish trips and speaker dinners given for doctors were purportedly kickbacks and used to induce them to prescribe Novartis drugs, according to court documents (this is the lawsuit filed by the feds).

As the litigation plays out, a key issue to watch is the extent to which a so-called Corporate Integrity Agreement that Novartis signed in 2010 factors into the proceedings. These agreements typically run for five years and require a company to establish an internal compliance program and report violations.

At the time that Preet Bharara, the U.S. Attorney in New York, announced the lawsuits against Novartis two years ago, he called the drug maker a “repeat offender,” and the lawsuits noted that the violations alleged in the litigation took place before and after the CIA was signed.

On paper, this could pose a problem for Novartis, because if the drug maker loses one or both cases, it may face exclusion – a term that means it could be excluded from having contracts with federal health care programs. This could amount to a large loss of revenue.

On the other hand, the federal government may need to be cautious about excluding a drug maker that provides numerous needed medications, because doing so could unnecessarily harm many people.

One expert says exclusion is unlikely. “Do Corporate Integrity Agreements really matter? Show me a case where a company has violated a CIA and been excluded,” says Patrick Burns of Taxpayers Against Fraud, a non-profit that advocates for tough penalties and is partially funded by attorneys. “I’ve come to see Corporate Integrity Agreements as bird cage liner.”


http://blogs.wsj.com/pharmalot/2015...o-pay-60m-to-settle-novartis-kickback-scheme/



as exclusion appears to be the greater crime against humanity, any guesses on the timing and cost of the next settlement?

we've had at least 1/year since 2010.

do the math.



1987-07 $899,520 Sandoz PF Settling with European Union for infringing Article 85 (1) of the Treaty
1996-02 $41,300,000 Ciba-Geigy Settling class action suit for conspiring to illegally fix prices of drugs
1999-03 $10,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for failure to provide accurate pricing information for pharmaceuticals sold to VA
2000-01 $25,000,000 Alcon Inc. Settling with Bausch & Lomb Inc. for patent-infringement
2004-11 $175,000,000 Novartis Pharmaceutical Corporation Settling with 5,600 current & former saleswomen for gender discrimination
2005-02 $44,654,229 Novartis Pharmaceutical Corporation Settling FCA violations for giving free enteral nutrition infusion pumps if buying related products
2006-07 $121,000,000 Alcon Inc. Settling with Advanced Medical Optics Inc. over 4 patent lawsuits
2010-01 $185,000,000 Novartis Pharmaceutical Corporation Settling with federal officials over its marketing of epilepsy drug Trileptal
2010-02 $3,500,000 Novartis Pharmaceutical Corporation (Eon Labs Inc.) Settling FCA violations for unapproved product - Nitroglycerin
2010-03 $579,338 Novartis Pharmaceutical Corporation Settling with Mary Kate Breeden for retaliation under the Family & Medical Leave Act
2010-05 $72,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for off-label marketing
2010-07 $152,500,000 Novartis Pharmaceutical Corporation Settling gender discrimination class action lawsuit
2010-09 $422,500,000 Novartis Pharmaceutical Corporation Settling FCA violations for off-label marketing
2010-10 $10,000,000 Novartis Pharmaceutical Corporation Settling with Hawaii for gouging Hawaii's Medicaid program for more than a decade by inflating prices
2011-09 $66,000,000 Novartis Pharmaceutical Corporation Settling FCA violations for overcharging Medicaid
2012-01 $99,170,000 Novartis Pharmaceutical Corporation Settling class-action lawsuit involving thousands of current & former employees for unpaid overtime
2013-12 $7,559,605 Novartis Pharmaceutical Corporation Settling with European Union for colluding with Johnson & Johnson to keep generic fentanyl out of Netherlands
2014-03 $126,340,273 Novartis Pharmaceutical Corporation Settling with Italy for colluding with Roche Holding to block Roche's Avastin drug for a more expensive one

https://docs.google.com/spreadsheets/d/1t0Tb5H7V_OkOuLM9kaiPmszXb3L5wS2g7Tc5dG7v9yM
Click to expand...

This must be the short list??
Just add in the clinical damages, price fixing, MD bribes and "incentives", and off label penalties and it starts to be real bucks.
 




Anonymous said:
This must be the short list??
Just add in the clinical damages, price fixing, MD bribes and "incentives", and off label penalties and it starts to be real bucks.
Click to expand...

Someone needs to investigate the incentives for these lawyers taking on these cases.
What they do is a form of bribery, forcing settlements because to fight it would cost even more.
 




Anonymous said:
Someone needs to investigate the incentives for these lawyers taking on these cases.
What they do is a form of bribery, forcing settlements because to fight it would cost even more.
Click to expand...

You're a funny guy!!!!!
No one "forces" settlements..companies "settle" TO AVOID ADMITTING GUILT.
Yep, these poor companies are just being harassed.
The Devil made me do it.
 




Anonymous said:
You're a funny guy!!!!!
No one "forces" settlements..companies "settle" TO AVOID ADMITTING GUILT.
Yep, these poor companies are just being harassed.
The Devil made me do it.
Click to expand...

It's not to avoid "admitting" guilt you moron. Any time you are taken to court, you run the chance of losing or being found guilty. It also costs a lot of money... Especially when the government gets involved with their endless play money. So, as a result, often times, companies settle. Some legitimate cases, but far too many shakedowns... Especially these government suits.
 




Anonymous said:
It's not to avoid "admitting" guilt you moron. Any time you are taken to court, you run the chance of losing or being found guilty. It also costs a lot of money... Especially when the government gets involved with their endless play money. So, as a result, often times, companies settle. Some legitimate cases, but far too many shakedowns... Especially these government suits.
Click to expand...

Hilarious.
You work in this industry??
 
























Top Bottom
Back
Quote